Skip to main content
Top
Published in: Forensic Science, Medicine and Pathology 3/2012

01-09-2012 | Original Article

The role of toxicology interpretations in prevention of sudden death

Authors: Jennifer L. Pilgrim, Dimitri Gerostamoulos, Olaf H. Drummer

Published in: Forensic Science, Medicine and Pathology | Issue 3/2012

Login to get access

Abstract

Inappropriate combinations of pharmaceutical drugs are often detected in deaths reported to a coroner. However, the involvement of drug combinations in the cause of death can be overlooked in cases when significant natural disease or external injury is also present. This study examined pathology reports and coroner’s findings between January 2002 and December 2008. Cases that included exposure to a selection of serotonergic drugs were examined to determine the role of different death investigators in drug-associated deaths in Victoria, Australia. Of the 326 cases identified, the involvement of drugs in the death was discussed to some degree in 66% of cases. Recommendations by the coroner pertaining to death prevention were made in 12 cases (4%). In 16 cases (5%) the drugs were not mentioned in the findings, including at least 11 cases of probable major adverse drug interactions. Death investigations serve an important public health and safety role, however, the potential involvement of drugs in many cases is not always recognized.
Literature
1.
go back to reference Australian Bureau of Statistics. Drug-induced death, Australia, 1991–2001. Canberra, Australia (2003) Contract No. 3321.0.55.001. Australian Bureau of Statistics. Drug-induced death, Australia, 1991–2001. Canberra, Australia (2003) Contract No. 3321.0.55.001.
2.
go back to reference Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003;15(Suppl 1):i49–59.PubMedCrossRef Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003;15(Suppl 1):i49–59.PubMedCrossRef
5.
go back to reference Curphey TJ. Role of the forensic pathologist in the medicolegal certification of modes of death. J Forensic Sci. 1968;13(2):163–76.PubMed Curphey TJ. Role of the forensic pathologist in the medicolegal certification of modes of death. J Forensic Sci. 1968;13(2):163–76.PubMed
6.
go back to reference Vanezis P. The role of the pathologist in the investigation of unexpected death in infancy (cot death). Med Sci Law. 1981;21(2):119–20.PubMed Vanezis P. The role of the pathologist in the investigation of unexpected death in infancy (cot death). Med Sci Law. 1981;21(2):119–20.PubMed
7.
go back to reference Manini AF, Nelson LS, Olsen D, Vlahov D, Hoffman RS. Medical examiner and medical toxicologist agreement on cause of death. Forensic Sci Int. 2011;206(1–3):71–6.PubMedCrossRef Manini AF, Nelson LS, Olsen D, Vlahov D, Hoffman RS. Medical examiner and medical toxicologist agreement on cause of death. Forensic Sci Int. 2011;206(1–3):71–6.PubMedCrossRef
8.
go back to reference Bugeja L, Ranson D. Coroners’ recommendations: a lost opportunity. J Law Med. 2005;13(2):173–5.PubMed Bugeja L, Ranson D. Coroners’ recommendations: a lost opportunity. J Law Med. 2005;13(2):173–5.PubMed
9.
go back to reference Studdert DM, Cordner SM. Impact of coronial investigations on manner and cause of death determinations in Australia, 2000–2007. Med J Aust. 2010;192(8):444–7.PubMed Studdert DM, Cordner SM. Impact of coronial investigations on manner and cause of death determinations in Australia, 2000–2007. Med J Aust. 2010;192(8):444–7.PubMed
10.
go back to reference Brodie L, Bugeja L, Ibrahim JE. Coroners’ recommendations following fatal heavy vehicle crash investigations. Aust N Z J Psychiatry. 2010;34(2):136–41. Brodie L, Bugeja L, Ibrahim JE. Coroners’ recommendations following fatal heavy vehicle crash investigations. Aust N Z J Psychiatry. 2010;34(2):136–41.
11.
go back to reference Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving serotonergic drugs. Forensic Sci Int. 2010;198(1–3):110–7.PubMedCrossRef Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving serotonergic drugs. Forensic Sci Int. 2010;198(1–3):110–7.PubMedCrossRef
12.
go back to reference Department of Health and Ageing (DHA). Pharmaceutical benefits scheme expenditure and prescriptions twelve months to 30 June 2007. Department of Health and Ageing (DHA). Pharmaceutical benefits scheme expenditure and prescriptions twelve months to 30 June 2007.
13.
go back to reference Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving contraindicated and inappropriate combinations of serotonergic drugs. Int J Legal Med. 2011;125(6):803–15.PubMedCrossRef Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving contraindicated and inappropriate combinations of serotonergic drugs. Int J Legal Med. 2011;125(6):803–15.PubMedCrossRef
14.
go back to reference Buajordet I, Ebbesen J, Erikssen J, Brors O, Hilberg T. Fatal adverse drug events: the paradox of drug treatment. J Intern Med. 2001;250(4):327–41.PubMedCrossRef Buajordet I, Ebbesen J, Erikssen J, Brors O, Hilberg T. Fatal adverse drug events: the paradox of drug treatment. J Intern Med. 2001;250(4):327–41.PubMedCrossRef
15.
go back to reference Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med. 1996;14(5):447–50.PubMedCrossRef Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med. 1996;14(5):447–50.PubMedCrossRef
16.
go back to reference Eap CB, Bertschy G, Powell K, Baumann P. Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone. J Clin Psychopharmacol. 1997;17(2):113–7.PubMedCrossRef Eap CB, Bertschy G, Powell K, Baumann P. Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone. J Clin Psychopharmacol. 1997;17(2):113–7.PubMedCrossRef
18.
go back to reference Pilgrim JL, Gerostamoulos D, Drummer OH. Review: pharmacogenetic aspects of the effect of cytochrome p450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol. 2010;7(2):162–84.PubMedCrossRef Pilgrim JL, Gerostamoulos D, Drummer OH. Review: pharmacogenetic aspects of the effect of cytochrome p450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol. 2010;7(2):162–84.PubMedCrossRef
Metadata
Title
The role of toxicology interpretations in prevention of sudden death
Authors
Jennifer L. Pilgrim
Dimitri Gerostamoulos
Olaf H. Drummer
Publication date
01-09-2012
Publisher
Springer US
Published in
Forensic Science, Medicine and Pathology / Issue 3/2012
Print ISSN: 1547-769X
Electronic ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-011-9309-7

Other articles of this Issue 3/2012

Forensic Science, Medicine and Pathology 3/2012 Go to the issue